Inovio Pharmaceuticals' Potentially Hollow Victory Buys it More Time

As it moves its cancer vaccines and infectious disease therapies, such as hepatitis B and C, Ebola, and influenza, into later-stage studies, the costs to … Full Article http://j.gs/5sTq

Click here to read full article